We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Legal & General Global Healthcare & Pharmaceutical Class C - Income (GBP)

Sell:76.44p Buy:76.44p Change: 0.15p (0.20%)
Prices as at 17 November 2025
Sell:76.44p
Buy:76.44p
Change: 0.15p (0.20%)
You can buy or sell holdings in this fund through a Stocks and Shares ISA, Lifetime ISA, SIPP or Fund and Share Account
Prices as at 17 November 2025
Sell:76.44p
Buy:76.44p
Change: 0.15p (0.20%)
Prices as at 17 November 2025
You can buy or sell holdings in this fund through a Stocks and Shares ISA, Lifetime ISA, SIPP or Fund and Share Account
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Asset Allocation

X-ray asset allocation
Key % Net Assets
International Equities 93.73%
UK Equities 5.75%
Cash and Equiv. 0.51%
Mutual Funds 0.00%

Top 10 holdings

Stock name % Weight Country Sector
1 ELI LILLY AND COMPANY 9.26% USA Pharmaceuticals & Biotechnology
2 JOHNSON & JOHNSON 6.18% USA Pharmaceuticals & Biotechnology
3 ABBVIE 5.29% USA Pharmaceuticals & Biotechnology
4 UNITEDHEALTH GROUP INCORPORATED 4.28% USA Health Care Providers
5 ROCHE HOLDING AG 3.17% CHE Pharmaceuticals & Biotechnology
6 NOVARTIS AG 3.14% CHE Pharmaceuticals & Biotechnology
7 ASTRAZENECA 2.95% GBR Pharmaceuticals & Biotechnology
8 ABBOTT LABORATORIES 2.93% USA Medical Equipment & Services
9 MERCK & CO INC(NEW) 2.92% USA Pharmaceuticals & Biotechnology
10 THERMO FISHER SCIENTIFIC 2.91% USA Medical Equipment & Services

Fund Analysis is only available on the desktop version of our website. This can be accessed using a desktop or laptop PC or some larger tablets.

You can buy or sell holdings in this fund through a Stocks and Shares ISA, Lifetime ISA, SIPP or Fund and Share Account